Recombinant REEP2 is a full-length 268-amino-acid protein (UniProt ID: Q4KMI4) expressed in Escherichia coli with an N-terminal His tag for purification . Key features include:
REEP2 belongs to the REEP family, which modulates G-protein-coupled receptor (GPCR) trafficking and membrane organization . Its hydrophobic domains enable interactions with lipid bilayers, influencing membrane curvature .
REEP2 enhances ligand sensitivity of taste receptors (e.g., T1R2/T1R3 sweet receptors) by recruiting them into lipid raft microdomains near apical membranes, improving signal transduction . Unlike REEP1, it does not increase surface receptor expression but reorganizes spatial distribution .
Heterologous Expression: Coexpression of REEP2 with T1R2/T1R3 in HEK293E cells increased responses to sweet ligands (e.g., glucose, sucralose) by ~3-fold .
Lipid Raft Recruitment: Sucrose density gradient assays confirmed REEP2-dependent localization of sweet receptors in lipid rafts, enhancing GPCR signaling efficiency .
Pathological Relevance: Mutations in REEP2 are linked to hereditary spastic paraplegia (HSP) due to disrupted ER morphology and microtubule interactions .
Commercial vendors employ distinct expression systems and purification strategies:
REEP2-specific antibodies (e.g., Proteintech 15684-1-AP) are widely used for detecting endogenous and recombinant proteins:
STRING database analysis highlights REEP2’s role in ER membrane remodeling and microtubule dynamics :
HSP Pathogenesis: The p.Val36Glu mutation in REEP2 disrupts membrane binding, leading to ER sheet expansion and axonal degeneration .
Taste Receptor Modulation: REEP2’s role in lipid raft organization provides insights into taste transduction and potential therapeutic targets for metabolic disorders .
May enhance cell surface expression of odorant receptors.
REEP2 in Danio rerio, like its mammalian counterparts, belongs to the DP1/Yop1p family of endoplasmic reticulum (ER)-shaping proteins. Its primary function involves modulating membrane curvature through insertion of hydrophobic hairpin domains into the ER membrane . This protein plays a crucial role in:
Shaping and organizing the endoplasmic reticulum architecture
Potentially facilitating interactions between the ER and microtubule cytoskeleton
Contributing to proper protein trafficking through the secretory pathway
Maintaining cellular homeostasis, particularly in neurons where REEP2 is highly expressed
Experimental evidence from studies with REEP family proteins demonstrates that loss of these proteins affects ER organization, as observed in mouse models with REEP1 deficiency . The highly conserved nature of REEP proteins across species suggests similar fundamental functions in zebrafish.
While the search results don't provide comprehensive tissue-specific expression data for Danio rerio REEP2, studies of REEP2 in other species indicate it is highly expressed in the brain and testis . This suggests a potentially similar expression pattern in zebrafish, though direct experimental validation is needed for confirmation.
The restricted expression pattern in specific tissues implies specialized functions in neuronal and reproductive systems. Unlike ubiquitously expressed proteins, this tissue-specific expression indicates REEP2 may have specialized roles in neural development, function, or maintenance in zebrafish. Future research using techniques such as in situ hybridization or tissue-specific RNA-seq would be valuable to precisely map REEP2 expression patterns throughout zebrafish development and in adult tissues.
Based on available data, the following protocol represents the optimal approach for expression and purification of recombinant Danio rerio REEP2:
Expression System:
Vector considerations: Vectors similar to those used for other membrane-associated proteins would be appropriate
Expression Conditions:
For membrane proteins like REEP2, careful control of expression is critical to prevent toxicity to host cells. Drawing from experience with other zebrafish proteins:
Consider using KRX cells (a derivative of E. coli K12) for expression, as they provide precise control of gene expression and minimize leaky expression that could be toxic
Induce expression with appropriate inducer (e.g., rhamnose if using the rhamnose promoter system)
Optimal temperature for expression would likely be 18-25°C to facilitate proper folding
Purification Protocol:
Cell lysis in an appropriate buffer containing detergents to solubilize membrane proteins
Storage as lyophilized powder or in buffer containing 50% glycerol at -20°C/-80°C
Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Storage Buffer Components:
For experimental applications requiring high purity, additional purification steps such as size exclusion chromatography may be necessary to achieve >90% purity as determined by SDS-PAGE .
Membrane binding is a critical functional property of REEP2, and mutations affecting this capacity have been linked to pathological conditions in humans, including hereditary spastic paraplegias . To assess REEP2 membrane binding, researchers can employ several complementary approaches:
Subcellular Fractionation Assay:
Express tagged REEP2 (wild-type or mutant variants) in an appropriate cell line
Perform subcellular fractionation to separate membrane-bound from soluble proteins
Analyze distribution using Western blotting with anti-tag antibodies
Compare the ratio of membrane-bound to soluble REEP2 across different variants
Liposome Flotation Assay:
This in vitro approach directly measures membrane binding capacity:
Express and purify recombinant REEP2 protein
Prepare liposomes with composition mimicking ER membranes
Incubate protein with liposomes, then perform density gradient centrifugation
Collect fractions and analyze protein distribution by Western blotting
Fluorescence Microscopy Approach:
Express fluorescently-tagged REEP2 variants in cells
Co-stain with ER markers (e.g., calnexin or PDI)
Analyze colocalization using confocal microscopy
Quantify the degree of membrane association through colocalization analysis
When conducting these assays, it's critical to include appropriate controls such as known membrane-binding deficient variants (e.g., the p.Val36Glu variant which has been shown to impair membrane binding) .
REEP2, like other REEP family proteins, potentially interacts with microtubules, which may be important for its function in organizing the ER network. Based on information about related REEP proteins, the following methodological approaches would be effective:
Co-immunoprecipitation of REEP2 with Tubulin:
Prepare zebrafish tissue or cell lysates (brain tissue would be optimal given REEP2's expression pattern)
Perform immunoprecipitation using anti-REEP2 antibodies
Detect co-precipitated tubulin by Western blotting with anti-tubulin antibodies
Include appropriate controls (non-specific IgG, tubulin-binding deficient mutants)
Immunofluorescence Colocalization Studies:
Express fluorescently-tagged REEP2 in cell models
Stain microtubules with appropriate antibodies
Analyze colocalization using high-resolution confocal or super-resolution microscopy
Quantify colocalization coefficients and perform statistical analysis
Microtubule Cosedimentation Assay:
Purify recombinant REEP2 protein
Prepare stabilized microtubules in vitro
Incubate REEP2 with microtubules
Perform centrifugation to pellet microtubules and associated proteins
Analyze pellet and supernatant fractions by SDS-PAGE and Western blotting
In vivo Analysis using CRISPR/Cas9 Models:
Generate zebrafish lines with fluorescently-tagged REEP2 using CRISPR/Cas9 genome editing
Perform live imaging of tagged REEP2 in relation to microtubule dynamics
Compare wild-type with mutant variants having altered microtubule binding domains
Previous studies have demonstrated that both wild-type REEP2 and the p.Val36Glu variant interact with microtubules , suggesting that this function may be preserved even when membrane binding is compromised.
Zebrafish (Danio rerio) represents an excellent model organism for studying REEP2-associated diseases due to its genetic tractability, transparent embryos for imaging, and the conservation of REEP2 function across species. Mutations in human REEP2 are associated with hereditary spastic paraplegias (HSPs), a group of neurological conditions characterized by progressive spasticity and weakness of the lower limbs . To develop zebrafish models:
CRISPR/Cas9 Gene Editing Approach:
Design guide RNAs targeting the zebrafish reep2 gene
Introduce specific mutations corresponding to human disease-causing variants:
Confirm mutations through sequencing
Establish stable transgenic lines
Phenotypic Analysis:
Motor behavior assessment using standardized swimming assays
Neuroanatomical analysis focusing on motor neuron development and axonal integrity
Electrophysiological recordings to assess neural function
ER morphology studies in affected neurons using transmission electron microscopy
Rescue Experiments:
Attempt rescue of phenotypes by introducing wild-type human REEP2
Compare efficacy of rescue between different mutant forms
Test potential therapeutic compounds that might compensate for REEP2 dysfunction
The advantage of the zebrafish model is that it enables investigation of both dominant and recessive inheritance patterns associated with different REEP2 mutations, as observed in human families . Molecular phenotyping can help explain how different mutations cause disease through distinct mechanisms (dominant-negative effect versus loss-of-function).
REEP2's function in ER shaping requires specialized experimental approaches to visualize and quantify changes in ER morphology. Key considerations include:
Visualization Techniques:
High-resolution imaging using techniques such as:
Confocal microscopy with ER-specific markers
Super-resolution microscopy (STED, PALM, or STORM) for detailed ER structure
Transmission electron microscopy for ultrastructural analysis
Live cell imaging to capture dynamic changes in ER morphology
Quantitative Analysis Methods:
Morphometric analysis of ER structure:
Tubule length and branching frequency
Sheet-to-tubule ratio
Three-dimensional reconstruction of ER networks
Statistical approaches to quantify structural differences between wild-type and mutant conditions
Experimental Controls and Variables:
Include both positive controls (known ER-shaping protein mutants) and negative controls
Consider cell-type specific effects, as REEP2 function may vary between different cell types
Evaluate temporal aspects of ER remodeling during development or under stress conditions
Compare effects of different REEP2 mutations:
Functional Assays:
Assess ER stress responses using appropriate markers (e.g., XBP1 splicing, ATF6 activation)
Evaluate calcium homeostasis, as ER shape affects calcium signaling
Measure effects on protein trafficking and secretion
Investigate interactions with other ER-shaping proteins through proximity labeling techniques
The evidence from human studies suggests that loss of association of REEP2 with membranes leads to pathological conditions , highlighting the importance of proper experimental design to capture subtle changes in ER morphology that may have significant functional consequences.
Danio rerio REEP2 belongs to the larger REEP/DP1/Yop1p family of proteins, which can be divided into two subfamilies based on sequence homology and function. A comprehensive comparison reveals:
Structural Comparison:
N-terminal Domain:
REEP2 contains two highly conserved hydrophobic domains at its N-terminus, a feature shared with REEP1, REEP3, and REEP4
These domains form hairpins that insert into membranes and promote oligomerization
The p.Phe72Tyr mutation site in REEP2 is conserved across all REEP family members up to zebrafish
C-terminal Domain:
Functional Comparison:
Membrane Binding:
Expression Patterns:
Disease Associations:
Evolutionary Conservation:
The conservation of key amino acids like Phe72 in REEP2 from zebrafish to humans highlights the evolutionary importance of these residues for proper protein function . This conservation provides a strong rationale for using zebrafish as a model organism to study REEP2 function and related diseases.
When working with Danio rerio REEP2 versus mammalian REEP2 proteins, researchers should consider several important differences in experimental approaches:
Expression Systems:
For zebrafish REEP2:
For mammalian REEP2:
Mammalian expression systems may be preferred to ensure proper post-translational modifications
Insect cell systems might provide better yield for structural studies
Buffer Conditions:
Drawing from experiences with other zebrafish proteins compared to mammalian counterparts:
Salt Sensitivity:
Divalent Cation Requirements:
Functional Assays:
Temperature Considerations:
Zebrafish proteins have evolved to function at lower temperatures (optimal temperature ~28°C)
Experimental assays should account for temperature differences when comparing across species
pH Optima:
Optimal pH conditions may differ between zebrafish and mammalian proteins
Systematic testing of buffer conditions is recommended
Storage Stability:
For zebrafish REEP2, recommended storage conditions include:
Store at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use
Avoid repeated freeze-thaw cycles
These differences highlight the importance of optimizing experimental conditions specifically for Danio rerio REEP2 rather than assuming identical conditions to mammalian orthologs will be optimal.
Generating specific antibodies against Danio rerio REEP2 presents several challenges due to its membrane-associated nature and potential conservation with other REEP family members. The following approaches can help overcome these challenges:
Antigen Design Strategies:
Peptide-based approach:
Select unique epitopes not conserved in other REEP family proteins
Focus on hydrophilic regions of the protein that are likely accessible
Avoid the highly conserved hydrophobic domains to prevent cross-reactivity
Recombinant protein fragments:
Immunization Protocols:
Use of multiple species:
Generate antibodies in rabbits for polyclonal antibodies
Consider hamster or guinea pig for additional specificity, as they may recognize different epitopes than rabbit antibodies
Adjuvant selection:
Choose adjuvants that enhance immune response without causing protein denaturation
Consider gentle adjuvants for membrane proteins
Purification and Validation Strategies:
Affinity purification:
Purify antibodies using immobilized antigen
Perform negative selection against related REEP proteins to remove cross-reactive antibodies
Comprehensive validation:
Test antibody specificity in REEP2 knockout/knockdown models
Verify recognition of both denatured (Western blot) and native (immunoprecipitation) forms
Perform preabsorption tests with immunizing antigen
Cross-reactivity testing:
Test against other REEP family members expressed in the same tissues
Evaluate in multiple assays (immunoblotting, immunohistochemistry, etc.)
Alternative Approaches:
If generating specific antibodies proves challenging, consider:
Epitope tagging approaches:
Generate transgenic zebrafish lines expressing tagged versions of REEP2
Use commercial antibodies against the tag for detection
Proximity labeling methods:
Use BioID or APEX2 fusion proteins to identify REEP2-proximal proteins
This avoids the need for direct REEP2 antibodies
Mutagenesis studies of REEP2 in zebrafish require careful consideration of several critical parameters to ensure successful outcomes:
Target Selection:
Disease-relevant mutations:
Functional domain targeting:
Target the N-terminal hydrophobic domains involved in membrane interaction
Consider residues at the interface between REEP2 and potential binding partners
Mutagenesis Strategies:
CRISPR/Cas9 approach:
Design specific guide RNAs with minimal off-target effects
Consider using base editors for precise point mutations
Include PAM site mutations that don't affect protein function to prevent re-cutting
Homology-directed repair:
Provide donor templates containing desired mutations
Include silent mutations to facilitate genotyping
Consider using long homology arms to increase efficiency
Genotyping Considerations:
Screening strategy:
Design primers for efficient screening of founders
Establish restriction enzyme digestion assays when possible
Consider high-resolution melting analysis for point mutations
Verification methods:
Confirm mutations by sequencing
Verify germline transmission
Check for potential off-target effects in critical genes
Phenotypic Analysis Parameters:
Developmental timing:
Assess phenotypes at multiple developmental stages
Consider potential compensatory mechanisms in early development
Tissue-specific effects:
Focus analysis on tissues with high REEP2 expression (brain)
Perform cell-type specific analyses within these tissues
Functional readouts:
ER morphology assessment
Motor behavior analysis
Electrophysiological measurements in relevant neuronal populations
Molecular phenotyping:
Controls and Validation:
Include appropriate controls:
Wild-type siblings
Different allelic variants (null versus point mutations)
Rescue experiments with wild-type human REEP2
The successful implementation of these parameters will enable meaningful mutagenesis studies that provide insight into REEP2 function in zebrafish and its relevance to human disease.
Based on current knowledge and gaps in understanding, several promising research directions emerge:
Comprehensive Expression Mapping:
Detailed characterization of REEP2 expression patterns throughout zebrafish development
Cell-type specific expression analysis in the brain
Regulatory mechanisms controlling REEP2 expression
High-Resolution Structural Studies:
Cryo-EM or X-ray crystallography studies of REEP2 interaction with membranes
Structural analysis of REEP2 oligomers and their membrane-shaping properties
Conformational changes associated with disease-causing mutations
In vivo Functional Studies:
Generation of zebrafish models with mutations equivalent to human disease variants
Live imaging of ER dynamics in REEP2 mutant neurons
Rescue experiments with structure-guided engineered variants
Interactome Analysis:
Comprehensive identification of REEP2 binding partners
Comparison with other REEP family members to identify unique interactions
Determination of tissue-specific interaction networks
Therapeutic Development:
Screens for compounds that can rescue REEP2 mutant phenotypes
Development of strategies to enhance membrane binding of defective REEP2 variants
Gene therapy approaches for REEP2-associated diseases
The zebrafish model offers unique advantages for these studies due to its genetic tractability, transparent embryos for imaging, and conservation of REEP2 function . The reference cross DNA panel for zebrafish, consisting of 520 F2 progeny, provides a valuable resource for genetic mapping studies that may further elucidate REEP2 function and regulation .
An integrative approach combining multiple disciplines represents the most promising strategy to fully elucidate REEP2 function:
Structural Biology Contributions:
Determination of REEP2 structure in membrane-bound state
Analysis of conformational changes associated with disease-causing mutations
Structural basis for REEP2 oligomerization and membrane curvature induction
Genetic Approaches:
CRISPR/Cas9-based generation of zebrafish models with specific REEP2 mutations
Forward genetic screens to identify genetic modifiers of REEP2 function
Utilization of the reference cross DNA panel for fine mapping of genetic interactions
Cell Biology Techniques:
Advanced imaging of ER dynamics in living cells
Analysis of REEP2's role in ER-microtubule contact sites
Investigation of REEP2's impact on secretory pathway function
Integration Methods:
Combined structural-functional studies:
Structure-guided mutagenesis to test specific hypotheses
Correlation of structural features with functional outcomes in vivo
Multi-omics integration:
Correlation of transcriptomic, proteomic, and lipidomic data
Network analysis to position REEP2 in cellular pathways
Cross-species comparative approaches:
Parallel studies in zebrafish and mammalian models
Evolutionary analysis of REEP protein function
Translation to disease mechanisms:
Direct testing of patient-derived mutations in zebrafish
Development of zebrafish-based platforms for therapeutic screening